Meadowsweet Safety: Who Should Avoid It

Most herbal teas need a paragraph of general caution. Meadowsweet needs a whole page, and for one specific reason: it delivers salicylates. Everything on this page follows from that single chemical fact. If you have read Meadowsweet, Salicylates and the Aspirin Story, you already know the mechanism; this page turns it into a list of people who should not drink it.

Two framing points before the list. First, meadowsweet is not a dangerous plant in ordinary use by ordinary adults — it is a traditional European tea with a long record and no reputation for poisoning anyone. Second, its risks are concentrated in specific groups, and for a couple of those groups the potential harm is serious rather than theoretical. That combination — broadly benign, sharply contraindicated — is exactly the shape that gets people into trouble, because "it is just a herbal tea" is true for most readers and dangerously wrong for a few.

Why the Cautions Exist
Salicylate Sensitivity and Aspirin Allergy
Aspirin-Sensitive Asthma
Children, Teenagers and Reye's Syndrome
Anticoagulants and Antiplatelets
Active Peptic Ulcer and Bleeding Risk
Pregnancy and Breastfeeding
Other Cautions Worth Knowing
Rosaceae and Plant-Family Allergy
The Unstandardised Dose Problem
Cautions You Can Ignore — and One People Get Backwards
Key Research Papers
Connections

Why the Cautions Exist

Meadowsweet's flowering tops contain salicylate glycosides (monotropitin, spiraein), salicylaldehyde, methyl salicylate and a little free salicylic acid. Once hydrolysed — largely by gut bacteria — and metabolised, what circulates is salicylate. It is the same anion your body deals with after taking aspirin, arriving more slowly, more variably, at a lower and unknown dose, and without an acetyl group.

That last point cuts both ways, and getting it right is the whole art of reading this page:

No acetylation means the aspirin-specific harms are weaker. The irreversible platelet inhibition and the potent COX-1 blockade that drives gastric injury both depend on acetylation. Meadowsweet cannot do those things well. This is the basis of its gentler reputation, and it is chemically legitimate.
Salicylate itself is what several of the serious reactions respond to. Salicylate sensitivity, aspirin-exacerbated respiratory disease and the Reye's syndrome association are reactions to salicylate exposure. They do not require acetylation. This is why "it is not really aspirin" is not a safety exemption.

So the correct rule is not "treat it exactly like aspirin" and not "it is only a tea." It is: the salicylate-mediated contraindications apply in full; the acetylation-mediated risks apply in weakened and uncertain form.

Salicylate Sensitivity and Aspirin Allergy

Avoid completely. This is the clearest contraindication on the page.

If you have ever reacted to aspirin or another salicylate — hives, facial or lip swelling, flushing, wheeze, nasal congestion, abdominal cramping, or anything resembling anaphylaxis — do not drink meadowsweet. The reaction is to salicylate, and meadowsweet supplies salicylate. The fact that it arrives as a plant glycoside rather than a tablet does not make the reactive molecule different.

Points people get wrong here:

Most "aspirin allergy" is not true immune allergy. Reactions to NSAIDs are frequently pharmacological — driven by COX inhibition shifting arachidonic acid metabolism — rather than IgE-mediated. That distinction matters for a clinician choosing an alternative, but it does not soften the advice here. Both mechanisms respond to salicylate.
A previous mild reaction does not predict a mild next one. NSAID hypersensitivity reactions are not reliably graded, which is why the professional guidelines are conservative about re-exposure.
"Natural" does not attenuate it. A dose you cannot measure is the worst possible way to re-challenge yourself with a compound you react to.

Tier: established — classification and management guidelines for NSAID hypersensitivity are well developed, and the salicylate content of meadowsweet is analytically documented.

Aspirin-Sensitive Asthma

Avoid. This is the caution most often skipped in herbal write-ups, and it is the one where a reaction can be severe.

Aspirin-exacerbated respiratory disease (AERD) — also called NSAID-exacerbated respiratory disease, and historically Samter's triad — is a distinct condition combining asthma, chronic rhinosinusitis with nasal polyps, and reactions to aspirin and other COX-1-inhibiting drugs. The mechanism is not allergy: COX-1 inhibition diverts arachidonic acid down the 5-lipoxygenase pathway, producing a surge of cysteinyl leukotrienes that triggers bronchoconstriction and severe upper-airway symptoms. Reactions can be dramatic and have caused fatalities.

It is not rare. A meta-analysis of prevalence in the asthma population put AERD at roughly 7% of adults with asthma, with substantially higher figures in severe asthma and much higher again among people who have both asthma and nasal polyps. So among readers with asthma, a meaningful minority is at risk.

What this means for meadowsweet:

If you have asthma with nasal polyps, or asthma and a known aspirin/NSAID reaction, avoid meadowsweet entirely.
If you have asthma and have never taken an NSAID, be cautious — an unmeasured salicylate dose is a poor way to discover you have AERD.
The dose question is genuinely uncertain here. AERD reactions are dose-related and typically provoked by therapeutic drug doses, so a weak herbal infusion may well be below anyone's threshold. Nobody knows, because neither the herb's salicylate content nor any individual's threshold is measured. When the potential outcome is a severe asthma attack, an unquantified risk is not one to take casually.

Tier: established for the drug reaction (well-documented mechanism, prevalence meta-analysis, clinical guidelines); inferred for the herb. Background on the condition sits on Asthma.

Children, Teenagers and Reye's Syndrome

Do not give meadowsweet to children or teenagers — and absolutely not during a viral illness such as influenza or chickenpox.

Reye's syndrome is a rare but often fatal illness of acute encephalopathy with fatty degeneration of the liver, described in the 1960s and occurring predominantly in children recovering from a viral infection. Epidemiological studies in the late 1970s and early 1980s linked it to salicylate exposure during that illness. Public health warnings against giving aspirin to children followed in the early 1980s, and reported cases in the United States and United Kingdom fell dramatically afterwards — one of the clearer natural experiments in paediatric drug safety. The association is with salicylates, not specifically with acetylsalicylic acid, which is why paediatric guidance covers salicylate-containing products generally.

Three honest qualifications, none of which change the advice:

No case of Reye's syndrome has been attributed to meadowsweet. The caution is precautionary and mechanistic, extrapolated from salicylate class safety.
The dose in a tea is probably far below aspirin's paediatric antipyretic dose. Probably. Unmeasured.
The tradition directly contradicts this. Meadowsweet was historically given to children for stomach upsets and fever, and you will find that recommendation repeated in herbal books. Where centuries of tradition collide with a documented drug-safety association carrying a high fatality rate, the modern evidence wins. This site is not going to soften that.

The overlap is uncomfortably precise: meadowsweet's classic traditional use is fever in a viral illness, and that is exactly the Reye's scenario. A child with a fever needs paracetamol or ibuprofen at a weight-appropriate dose, or nothing, or a doctor — not a salicylate herb.

Tier: established epidemiological association for salicylates; precautionary extrapolation for meadowsweet.

Anticoagulants and Antiplatelets

Caution; discuss with your prescriber before using. Here the honest answer is more nuanced than the standard warning, and the nuance is worth having.

The standard advice — do not combine meadowsweet with warfarin, direct oral anticoagulants, clopidogrel or aspirin — is what every herbal reference says, and this page agrees with it. But the mechanistic case is weaker than usually implied, and readers deserve to know why the caution still stands:

Non-acetylated salicylates barely affect platelets. Meadowsweet's salicylates are not acetylated, so the potent irreversible platelet inhibition that makes aspirin a bleeding risk is largely absent. Salsalate and other non-acetylated salicylate drugs are recognised as having minimal antiplatelet effect. On that reasoning alone, a meadowsweet interaction should be small.
But salicylate has other pathways to bleeding risk. Salicylate is highly protein-bound and can displace warfarin from albumin; high salicylate doses can interfere with haemostasis independently of platelets; and polyphenol-rich extracts show antiplatelet activity in vitro, though the human relevance of that is unclear.
The dose is unmeasurable and the consequence of being wrong is a bleed. This, rather than the mechanism, is the decisive argument. Anticoagulation is a narrow-margin business — warfarin in particular is monitored by INR precisely because small perturbations matter. Adding an unquantified salicylate exposure to a carefully titrated anticoagulant is a poor trade for a tea with no proven benefit.

Practical guidance: if you take any anticoagulant or antiplatelet, do not add meadowsweet without asking your prescriber. If you are on warfarin and take it anyway, tell whoever monitors your INR, because unexplained variability is exactly what they need to know about. Stop it well before planned surgery or dental extraction — the conventional advice for salicylate-containing herbs is one to two weeks, and your surgical team should be told.

Tier: theoretical interaction with a strong precautionary rationale; not a documented meadowsweet-specific interaction. Related reading: Aspirin: Bleeding Risks and Cautions.

Active Peptic Ulcer and Bleeding Risk

Avoid in active peptic ulcer disease, despite the traditional use. This is the one recommendation on the page that runs against the plant's most interesting property, so it needs justifying.

Meadowsweet is traditionally used for stomach complaints, and animal work does show gastroprotective activity — the 2018 Journal of Ethnopharmacology study is genuine and is discussed fully on Meadowsweet for Digestion and Stomach Comfort. So why avoid it in an actual ulcer?

The gastroprotection is preclinical. Rodent gastric-lesion models are not human peptic ulcers, and there is no human trial. Betting an active ulcer on a rodent result is a bad bet.
The downside is asymmetric. If the herb is neutral you gain nothing; if it is mildly irritating you risk a bleed or perforation. An active ulcer is not the place to test an uncertainty.
Tannins can irritate. Meadowsweet is markedly astringent, and concentrated tannins provoke nausea and gastric discomfort in some people, particularly on an empty stomach.
Ulcers have treatable causes. Helicobacter pylori eradication and acid suppression heal ulcers reliably. Substituting tea means an untreated ulcer, which is the real harm here — not the tea's direct effect. See Peptic Ulcer Disease.

The same reasoning extends to anyone with a history of gastrointestinal bleeding, oesophageal varices, or a bleeding disorder such as haemophilia or von Willebrand disease, and to anyone with a low platelet count.

Seek care rather than self-treating for: vomiting blood or coffee-ground material, black tarry stools, unexplained weight loss, difficulty swallowing, persistent vomiting, or new severe upper abdominal pain.

Pregnancy and Breastfeeding

Avoid. Two independent reasons, either sufficient on its own.

First, salicylates are generally avoided in pregnancy outside specific medical indications, and NSAIDs are contraindicated in the third trimester because of effects on the fetal ductus arteriosus and on labour. Where low-dose aspirin is used in pregnancy — for pre-eclampsia prevention, for example — it is prescribed and monitored deliberately, at a known dose, which is the opposite of an unstandardised tea.

Second, and more simply, there is no safety data for meadowsweet in pregnancy or lactation. No trials, no registry data, no systematic case series. "No known harm" here means nobody has looked, which is not reassurance.

Salicylates also pass into breast milk. Given the Reye's syndrome association in children, deliberately introducing an unmeasured salicylate to a nursing infant is not a sensible trade for a tea with no proven benefit.

Tier: established for salicylate drugs in pregnancy; absence of data for meadowsweet.

Other Cautions Worth Knowing

Do not stack it on aspirin or NSAIDs. If you already take aspirin, ibuprofen, naproxen or diclofenac, adding meadowsweet adds an unknown salicylate dose to a known one. There is no benefit to this and it makes your total exposure unmeasurable.
Kidney disease. Salicylates and NSAIDs are cleared renally and can affect renal blood flow. With significant chronic kidney disease, avoid adding unmeasured salicylate. See Aspirin and the Kidneys.
Liver disease. Salicylate is hepatically metabolised, and impaired liver function alters handling of it. Caution.
Gout and uric acid. Salicylates have a genuinely dose-dependent, biphasic effect on uric acid handling — low doses tend to reduce urate excretion (raising serum urate) while high doses are uricosuric. Where an unmeasured herbal dose falls on that curve is unknown, so treat meadowsweet with caution in gout rather than assuming it helps.
Methotrexate. Salicylates can reduce methotrexate clearance and raise its toxicity; the interaction is documented for salicylate drugs. Do not combine without specialist advice.
Surgery and dental procedures. Stop one to two weeks beforehand and tell your team.
Iron absorption. Tannin-rich teas reduce non-haem iron absorption when drunk with meals. If you are managing iron-deficiency anaemia, take astringent teas between meals rather than with them.
Correct identification. If you are wildcrafting rather than buying, identify carefully. Meadowsweet grows in damp ground alongside plants that are not benign, and confident plant identification is a skill, not a guess. Buy from a reputable herb supplier if you are not certain.
Duration. Traditional use is short-term and symptomatic. Continuous long-term daily use has never been studied, and there is no basis for calling it safe indefinitely.

Rosaceae and Plant-Family Allergy

Meadowsweet is a member of Rosaceae, the rose family — the same family as apple, pear, cherry, plum, peach, apricot, almond, strawberry, raspberry and blackberry. Two implications, both modest.

First, a general one: people with pollen-food allergy syndrome frequently react to Rosaceae fruits, driven by allergens including profilins and lipid-transfer proteins. Whether that translates to a reaction to a Rosaceae flower infusion is not established — there is no documented pattern of meadowsweet allergy in people allergic to Rosaceae fruits, and the allergens involved are not necessarily shared or heat-stable in a tea. It is a reasonable thing to be aware of, not a reason for most people to avoid the herb.

Second, a practical one: if you have significant Rosaceae fruit allergy, or a history of anaphylaxis to any plant food, introduce any new botanical cautiously and not when you are alone. That is generic good practice rather than a meadowsweet-specific warning.

Tier: established plant taxonomy; speculative cross-reactivity. Flagged for completeness, weighted accordingly.

The Unstandardised Dose Problem

Underneath every caution above sits one structural problem: you cannot know how much salicylate you are taking.

Every stage adds uncertainty. Salicylate content varies by plant part, population, harvest timing and growing conditions. Salicylaldehyde and methyl salicylate are volatile and are lost during drying, storage and uncovered brewing. Whether you cover the cup changes the result. And because the glycosides need bacterial hydrolysis to release their salicylate, the delivered dose depends on your own gut flora. No meadowsweet tea on the market is standardised to a salicylate content the way a willow bark extract can be standardised to salicin.

Be sceptical of confident milligram figures. Published analyses vary widely, tea products are not labelled for salicylate, and any single number quoted as "the" salicylate content of a cup of meadowsweet tea is at best one measurement of one batch.

What follows from this is a genuinely useful rule with two halves:

You cannot titrate it, so do not use it as though you could — not as a substitute for a measured analgesic dose, and not "one more cup" for a stronger effect.
You cannot rule it out either, so if a salicylate is contraindicated for you, an unmeasured salicylate is not the safe version of it.

Cautions You Can Ignore — and One People Get Backwards

Balance requires saying which warnings are overstated.

The coumarin claim is backwards. Meadowsweet's constituent list often includes coumarins, and this gets cited as evidence that the herb "thins the blood." That reasoning is wrong. Plain coumarin is a fragrant plant compound — the smell of new-mown hay — and it is not an anticoagulant. The anticoagulant is dicoumarol, which forms when coumarin-containing sweet clover spoils and moulds; that discovery led to warfarin. Coumarin in an intact, properly dried herb is not dicoumarol and does not thin blood. The plausible bleeding-related concern with meadowsweet is the salicylate one discussed above — getting the mechanism right matters, because a wrong mechanism produces wrong advice about what else is risky.

Meadowsweet is not a toxic plant. It has no reputation as a poisonous species, no characteristic toxidrome, and no history of serious harm in ordinary culinary and traditional use — it was used to flavour mead and beer, and to scent floors. For a healthy adult not in any group above, a cup or two of meadowsweet tea is a low-risk thing to drink.

The stomach caution is a genuine judgement call, not settled fact. This page advises avoiding it in active ulcer disease. That advice is precautionary and follows from the absence of human evidence rather than from any demonstrated harm. Somebody could reasonably argue the tradition and the animal data the other way. What nobody can honestly say is that the human evidence settles it, because there is none.

Key Research Papers

PubMed topic and title searches with evidence tiers. Note how many of the strongest citations concern salicylate drugs rather than meadowsweet — that is the accurate picture, and it is why this page reasons by extrapolation and says so.

Reye RD, Morgan G, Baral J. "Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood." Lancet, 1963. The original description of the syndrome. Tier: original clinical description. Search PubMed
Epidemiological studies linking salicylate use to Reye's syndrome, and the fall in cases after public health warnings. Including the surveillance data showing US cases declining sharply through the 1980s and 1990s. Tier: epidemiological, strong. Search PubMed
Reviews of the aspirin–Reye's syndrome evidence. Assessments of how strong the association is and how it shaped paediatric salicylate guidance. Tier: review of epidemiological evidence. Search PubMed
Prevalence meta-analysis of aspirin-exacerbated respiratory disease among people with asthma. The source of the roughly 7% figure quoted above, with higher rates in severe asthma. Tier: meta-analysis of prevalence studies. Search PubMed
Mechanistic and clinical literature on AERD. COX-1 inhibition, cysteinyl-leukotriene overproduction, and the asthma–nasal-polyp–NSAID-reaction triad. Tier: established mechanism plus clinical studies. Search PubMed
Guidelines on the classification, diagnosis and management of NSAID hypersensitivity. Including the distinction between true allergy and pharmacological cross-intolerance. Tier: expert guideline. Search PubMed
Comparative literature on non-acetylated salicylates. Salsalate and relatives — less gastric toxicity, minimal platelet effect. The evidence behind this page's "weakened but uncertain" framing. Tier: clinical pharmacology of drugs. Search PubMed
Salicylate–warfarin interaction literature, including protein-binding displacement. The mechanistic basis for the anticoagulant caution. Tier: pharmacokinetic and clinical (drugs). Search PubMed
Salicylate–methotrexate interaction literature. Reduced methotrexate clearance and increased toxicity. Tier: pharmacokinetic and clinical (drugs). Search PubMed
Literature on the biphasic, dose-dependent effect of salicylates on uric acid handling. Why the gout caution is genuinely uncertain rather than merely conventional. Tier: established human pharmacology. Search PubMed
NSAIDs and salicylates in pregnancy. Third-trimester contraindication, ductus arteriosus effects, and the separate deliberate use of prescribed low-dose aspirin. Tier: established clinical evidence. Search PubMed
Samardzic S and colleagues, on gastroprotective activity of Filipendula ulmaria. Journal of Ethnopharmacology, 2018. Included here because it is the evidence against part of this page's caution, and readers should see both sides. Tier: preliminary (animal). Search PubMed
Savina T and colleagues, on variation in meadowsweet's phenolic content between plant organs. Molecules, 2023. The analytical evidence that the dose in a tea cannot be known. Tier: analytical. Search PubMed
Dicoumarol, spoiled sweet clover and the origin of warfarin. The history that shows plain plant coumarin is not an anticoagulant. Tier: established history and pharmacology. Search PubMed
Rosaceae fruit allergy, profilins and lipid-transfer proteins. Background for the plant-family point, which remains speculative for meadowsweet. Tier: established for fruits; speculative for this herb. Search PubMed

External Resources

PubMed — the database behind the searches above.
NIH National Center for Complementary and Integrative Health — herb safety summaries and interaction warnings.
MedlinePlus — plain-language drug and supplement information.
DailyMed — official US prescribing information, useful for checking a medication's own salicylate and NSAID warnings.
European Medicines Agency — the traditional-use regulatory category that meadowsweet products fall under in Europe.

Connections

Safety and disclaimer. To summarise the whole page: avoid meadowsweet if you are sensitive to aspirin or salicylates, if you have aspirin-sensitive asthma or asthma with nasal polyps, if you are pregnant or breastfeeding, or if you are a child or teenager — especially during a viral illness. Do not combine it with anticoagulants, antiplatelets, methotrexate or other NSAIDs without your prescriber's agreement, and avoid it in active peptic ulcer disease or with any bleeding disorder. Because the salicylate dose in a tea cannot be measured, it cannot be titrated and it cannot be assumed to be negligible. This page is educational information, not medical advice, and it is not a reason to change or stop any prescribed medicine. Talk to your doctor or pharmacist about your own situation.

Back to Table of Contents